Literature DB >> 12727916

Double target for tumor mass destruction.

Pipsa Saharinen1, Kari Alitalo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12727916      PMCID： PMC154456          DOI： 10.1172/JCI18539

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  25 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

2.  PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.

Authors:  E Bergsten; M Uutela; X Li; K Pietras; A Ostman; C H Heldin; K Alitalo; U Eriksson
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

Review 3.  Vascular-specific growth factors and blood vessel formation.

Authors:  G D Yancopoulos; S Davis; N W Gale; J S Rudge; S J Wiegand; J Holash
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

Review 4.  Dissecting tumour pathophysiology using intravital microscopy.

Authors:  Rakesh K Jain; Lance L Munn; Dai Fukumura
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

5.  PDGF-D, a new protease-activated growth factor.

Authors:  W J LaRochelle; M Jeffers; W F McDonald; R A Chillakuru; N A Giese; N A Lokker; C Sullivan; F L Boldog; M Yang; C Vernet; C E Burgess; E Fernandes; L L Deegler; B Rittman; J Shimkets; R A Shimkets; J M Rothberg; H S Lichenstein
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

6.  Analysis of mural cell recruitment to tumor vessels.

Authors:  Alexandra Abramsson; Orjan Berlin; Hayk Papayan; Denise Paulin; Moshe Shani; Christer Betsholtz
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

7.  Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors.

Authors:  Shunichi Morikawa; Peter Baluk; Toshiyuki Kaidoh; Amy Haskell; Rakesh K Jain; Donald M McDonald
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

8.  Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy.

Authors:  Maria Enge; Mattias Bjarnegård; Holger Gerhardt; Erika Gustafsson; Mattias Kalén; Noomi Asker; Hans-Peter Hammes; Moshe Shani; Reinhardt Fässler; Christer Betsholtz
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

9.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Authors:  Aernout Luttun; Marc Tjwa; Lieve Moons; Yan Wu; Anne Angelillo-Scherrer; Fang Liao; Janice A Nagy; Andrea Hooper; Josef Priller; Bert De Klerck; Veerle Compernolle; Evis Daci; Peter Bohlen; Mieke Dewerchin; Jean-Marc Herbert; Roy Fava; Patrick Matthys; Geert Carmeliet; Désiré Collen; Harold F Dvorak; Daniel J Hicklin; Peter Carmeliet
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

Review 10.  Molecular mechanisms of lymphangiogenesis in health and disease.

Authors:  Kari Alitalo; Peter Carmeliet
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743
View more
  15 in total

1.  Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.

Authors:  Ugur Ozerdem; William B Stallcup
Journal:  Angiogenesis       Date:  2004       Impact factor: 9.596

2.  A hybrid model for three-dimensional simulations of sprouting angiogenesis.

Authors:  Florian Milde; Michael Bergdorf; Petros Koumoutsakos
Journal:  Biophys J       Date:  2008-06-27       Impact factor: 4.033

3.  The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma.

Authors:  Randy D'Amico; Liang Lei; Benjamin C Kennedy; Julia Sisti; Victoria Ebiana; Celina Crisman; James G Christensen; Orlando Gil; Steven S Rosenfeld; Peter Canoll; Jeffrey N Bruce
Journal:  Neurol Res       Date:  2012-03-05       Impact factor: 2.448

4.  Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis.

Authors:  Ugur Ozerdem; Kari Alitalo; Petri Salven; Andrew Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

Review 5.  NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.

Authors:  William B Stallcup; Weon-Kyoo You; Karolina Kucharova; Pilar Cejudo-Martin; Fusanori Yotsumoto
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

6.  Targeting neovascular pericytes in neurofibromatosis type 1.

Authors:  Ugur Ozerdem
Journal:  Angiogenesis       Date:  2005-05-09       Impact factor: 9.596

7.  An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature.

Authors:  Kaisa Lehti; Edward Allen; Henning Birkedal-Hansen; Kenn Holmbeck; Yasuhiro Miyake; Tae-Hwa Chun; Stephen J Weiss
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

8.  Vasculopathy in type 2 diabetes mellitus: role of specific angiogenic modulators.

Authors:  Enas A Hamed; Madeha M Zakary; Reffat M Abdelal; Effat M Abdel Moneim
Journal:  J Physiol Biochem       Date:  2011-02-19       Impact factor: 4.158

9.  Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene.

Authors:  Bao-Jin Li; Chao Zhang; Yuan-Xue Yi; Ying Hao; Xiao-Ping Liu; Qing-Jia Ou
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

10.  M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.

Authors:  Yoshiaki Kubota; Keiyo Takubo; Takatsune Shimizu; Hiroaki Ohno; Kazuo Kishi; Masabumi Shibuya; Hideyuki Saya; Toshio Suda
Journal:  J Exp Med       Date:  2009-04-27       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.